Search
-
2014 Fourth Quarter
Investors
https://www.gsk.com/en-gb/investors/quarterly-results/2014-fourth-quarter/
First published: 14 November 2023
-
2014 Third Quarter
Investors
https://www.gsk.com/en-gb/investors/quarterly-results/2014-third-quarter/
First published: 14 November 2023
-
2014 Second Quarter
Investors
https://www.gsk.com/en-gb/investors/quarterly-results/2014-second-quarter/
First published: 14 November 2023
-
2014 First Quarter
Investors
https://www.gsk.com/en-gb/investors/quarterly-results/2014-first-quarter/
First published: 14 November 2023
-
GSK statement on BBC Panorama programme
Media
GSK issued the following statement in response to claims by BBC Panorama related to GSK in Poland, to be broadcast on Monday April 14 2014
https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-bbc-panorama-programme/
First published: 14 April 2014
-
Q4 2014 analyst presentation
Media
https://www.gsk.com/media/2162/q4-2014-analyst-presentation.pdf
First published: 27 February 2017
-
Ebola Vaccine Journey Infographic
Media
https://www.gsk.com/media/2989/ebola-vaccine-journey-infographic.pdf
First published: 27 February 2017
-
Q4 2014 pre announcement aide memoire
Media
https://www.gsk.com/media/2157/q4-2014-pre-announcement-aide-memoire.pdf
First published: 27 February 2017
-
Q2 2014 pre announcement aide memoire
Media
https://www.gsk.com/media/2148/q2-2014-pre-announcement-aide-memoire.pdf
First published: 27 February 2017
-
GSK presents positive data at ATS 2014 from study evaluating efficacy and safety of Incruse™ Ellipta® added to Advair® Diskus® in patients with COPD
Media
GlaxoSmithKline plc (LSE:GSK) today presented data at the American Thoracic Society (ATS) from a late-stage clinical study.
https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-data-at-ats-2014-from-study-evaluating-efficacy-and-safety-of-incruse-ellipta-added-to-advair-diskus-in-patients-with-copd/
First published: 19 May 2014